Etiometry Platform Introduced, Company Broadens its Product Line of Hospital ICU Software Solutions
News and Press Releases
Etiometry Platform Provides Hospital ICUs with Actionable Information through Data Consolidation, Enhanced Visualization, and Dynamic Analytics
BOSTON, September 20, 2016—Etiometry, a pioneering leader in next-generation patient monitoring software, has introduced the Etiometry Platform. This end-to-end clinical data collection, analysis, visualization and archiving system collects physiologic data directly from patient monitoring devices while analyzing it in near-real time in the context of human physiology models and proven aerospace estimation methodologies.
The Etiometry Platform features a web-based architecture that is hosted in a hospital’s data center and protected by the hospital’s firewall, and it encompasses all of the Etiometry products under a unified architecture. These products include:
- T3 Visualization & Data Aggregation — An FDA-cleared software visualization application to collect, store, and visualize ICU data in near-real time. It includes new and proprietary data aggregation technologies developed by Etiometry to enable the collection, segmentation, and near real-time patient binding of data to support patient care.
- Risk Analytics Algorithms — New Etiometry algorithms that are deployed on Etiometry’s T3 Visualization & Aggregation Software.
- Quality Improvement System — This clinical database from Etiometry allows researchers and quality improvement specialists to easily access high-fidelity data files for any individual or groups of patients.
All products within the Etiometry Platform are immediately available. “The Etiometry Platform enables more informed decision making, improved patient care quality, and decreased costs,” said Etiometry COO Evan Butler. “We’ve built out our software solution for broader ICU market penetration, and we’ve rounded out our ICU solutions portfolio under a single, integrated software framework.”About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Etiometry Significantly Enhances Platform Capabilities, Extending Insights Beyond the ICU
The addition of high-fidelity waveform data integration provides deeper insights and additional data points available in lower-acuity settings July 8, 2025 – BOSTON – Etiometry, a leader in clinical decision support software, has announced a significant advancement to its platform with the integration of high-fidelity waveform data to inform and improve existing clinical data interpretation. […]
Multicenter Study Demonstrates 29% Reduction in Vasoactive Infusion Time with Use of Etiometry’s AI Powered Clinical Intelligence Platform
Study published in Critical Care Medicine highlights impact of IDO2-informed decision support on reducing postoperative support duration June 17, 2025 – BOSTON – A newly published multicenter clinical trial in Critical Care Medicine shows that use of Etiometry’s Clinical Intelligence Platform—specifically its Inadequate Delivery of Oxygen (IDO2) Index—was associated with a significant reduction in the […]
Boston Children’s Hospital Multi-center Study Finds Etiometry’s Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery
Results published in Pediatric Critical Care Medicine demonstrate that the IDO2 and IVCO2 Indices may support more informed ventilator liberation decisions May 19, 2025 – BOSTON – A newly published multi-center study has found that Etiometry’s FDA-cleared physiologic risk analytics—IDO2 and IVCO2—were found to be associated with increased risk of extubation failure in retrospective analysis, […]